Research study Program year 2020 Source: CMS Open Payments

ABP 710 Ph3 RA Multi-Dose Global

Research payments

$301,833

33 payments

Through program year 2020, $301,833 in research payments was reported against ABP 710 Ph3 RA Multi-Dose Global, across 33 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$1,000	1
2019	Research	$300,833	32

Breakdown

Who paid Research payments · program years 2019–2020

Amgen Inc. $301,833 33 payments

Who received the money Research payments · program years 2019–2020

San Marcus Research Clinic INC Organisation paid for research $33,138 1 payment
Inland Rheumatology Clinical Trials Organisation paid for research $28,467 1 payment
Trinity Universal Research Associates, Inc. Organisation paid for research $27,940 2 payments
Low Country Rheumatology PA/Low Country Research Center Organisation paid for research $23,977 1 payment
Arthritis, Rheumatic & Back Disease Associates Organisation paid for research $21,647 1 payment
Medvin Clinical Research Organisation paid for research $16,663 2 payments
Gupta, Ramesh C. Organisation paid for research $14,718 1 payment
Arthritis Consultants, Inc. Organisation paid for research $13,876 1 payment
Rheumatology Associates Of North Alabama Organisation paid for research $13,397 1 payment
Accurate Clinical Research INC Organisation paid for research $12,410 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.